BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19744594)

  • 1. Contrast-induced nephropathy after intravenous administration: fact or fiction?
    Katzberg RW; Lamba R
    Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast media induced nephrotoxicity: problems in clinical practice.
    Stacul F; Cova M
    Radiol Med; 2003; 105(1-2):36-41. PubMed ID: 12700543
    [No Abstract]   [Full Text] [Related]  

  • 8. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
    Reddan D; Fishman EK
    Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging.
    Josephson SA; Dillon WP; Smith WS
    Neurology; 2005 May; 64(10):1805-6. PubMed ID: 15911820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
    Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
    Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephropathy in critically Ill patients without preexisting renal disease.
    Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
    Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of contrast-induced nephropathy: an overview.
    Ellis JH; Cohan RH
    Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced acute kidney injury (CIAKI).
    Solomon R
    Radiol Clin North Am; 2009 Sep; 47(5):783-8, v. PubMed ID: 19744593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the consequences of contrast-induced nephropathy.
    Nikolsky E; Mehran R
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S10-8. PubMed ID: 14668705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.